APO Research
Talk to an analyst

APO RESEARCH · REPORT

Quetiapine Fumarate

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Selected research

Industry Growth & Trends

Global Quetiapine Fumarate Industry Growth and Trends Forecast to 2032

26 December 2025100 pages

Choose your research edition.

Industry ResearchQuetiapine Fumarate Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Quetiapine Fumarate Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Quetiapine Fumarate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Quetiapine Fumarate Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Quetiapine Fumarate Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.

Europe is the largest Quetiapine Fumarate market with about 92% market share. China is follower, accounting for about 2% market share.

The key players are AstraZeneca, Intas, TAPI, Accord, Hexal, Dr.Reddy's, Lupin, Sun Pharmaceutical, Hunan Dongting Pharm, SuZhou NO.4 Phamaceutical Factory, Fuan Pharmaceutical, Zhejiang Supor Pharmaceuticals, Zhejiang Huahai Pharmaceutical etc. Top 3 companies occupied about 74% market share.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Quetiapine Fumarate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Quetiapine Fumarate market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Quetiapine Fumarate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Quetiapine Fumarate.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Quetiapine Fumarate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Quetiapine Fumarate Market by Company

AstraZeneca

Intas

TAPI

Accord

Hexal

Dr.Reddy's

Lupin

Sun Pharmaceutical

Hunan Dongting Pharm

SuZhou NO.4 Phamaceutical Factory

Fuan Pharmaceutical

Zhejiang Supor Pharmaceuticals

Zhejiang Huahai Pharmaceutical

Quetiapine Fumarate Segment by Type

Immediate Release Tablets

Extended Release Tablets

Quetiapine Fumarate Segment by Application

Adult

Others

Quetiapine Fumarate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine Fumarate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quetiapine Fumarate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine Fumarate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Quetiapine Fumarate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Quetiapine Fumarate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immediate Release Tablets Table 2. Major Company of Extended Release Tablets Table 3. Global Quetiapine Fumarate Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 5. Global Quetiapine Fumarate Sales Market Share in Volume by Type (2021-2026) Table 6. Global Quetiapine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 7. Global Quetiapine Fumarate Sales Market Share in Value by Type (2021-2026) Table 8. Global Quetiapine Fumarate Price by Type (2021-2026) & (USD/kg) Table 9. Global Quetiapine Fumarate Sales by Type (2027-2032) & (t) Table 10. Global Quetiapine Fumarate Sales Market Share in Volume by Type (2027-2032) Table 11. Global Quetiapine Fumarate Sales by Type (2027-2032) & (US$ Million) Table 12. Global Quetiapine Fumarate Sales Market Share in Value by Type (2027-2032) Table 13. Global Quetiapine Fumarate Price by Type (2027-2032) & (USD/kg) Table 14. North America Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 15. North America Quetiapine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 17. Europe Quetiapine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Quetiapine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 21. Latin America Quetiapine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Quetiapine Fumarate Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Quetiapine Fumarate Sales by Type (2021-2026) & (US$ Million) Table 24. Quetiapine Fumarate Industry Trends Table 25. Quetiapine Fumarate Industry Drivers Table 26. Quetiapine Fumarate Industry Opportunities and Challenges Table 27. Quetiapine Fumarate Industry Restraints Table 28. Global Quetiapine Fumarate Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Quetiapine Fumarate Revenue Market Share by Company (2021-2026) Table 30. Global Quetiapine Fumarate Sales by Company (2021-2026) & (t) Table 31. Global Quetiapine Fumarate Sales Share by Company (2021-2026) Table 32. Global Quetiapine Fumarate Market Price by Company (2021-2026) & (USD/kg) Table 33. Global Quetiapine Fumarate Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Quetiapine Fumarate Major Company Production Sites and Headquarters Table 35. Global Quetiapine Fumarate Company, Product Type & Application Table 36. Global Quetiapine Fumarate Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Quetiapine Fumarate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Quetiapine Fumarate Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Quetiapine Fumarate Sales by Region (2021-2026) & (t) Table 41. Global Quetiapine Fumarate Sales Market Share in Volume by Region (2021-2026) Table 42. Global Quetiapine Fumarate Sales by Region (2021-2026) & (US$ Million) Table 43. Global Quetiapine Fumarate Sales Market Share in Value by Region (2021-2026) Table 44. Global Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global Quetiapine Fumarate Sales by Region (2027-2032) & (t) Table 46. Global Quetiapine Fumarate Sales Market Share in Volume by Region (2027-2032) Table 47. Global Quetiapine Fumarate Sales by Region (2027-2032) & (US$ Million) Table 48. Global Quetiapine Fumarate Sales Market Share in Value by Region (2027-2032) Table 49. Global Quetiapine Fumarate Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global Quetiapine Fumarate Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 52. Global Quetiapine Fumarate Sales Market Share in Volume by Application (2021-2026) Table 53. Global Quetiapine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 54. Global Quetiapine Fumarate Sales Market Share in Value by Application (2021-2026) Table 55. Global Quetiapine Fumarate Price by Application (2021-2026) & (USD/kg) Table 56. Global Quetiapine Fumarate Sales by Application (2027-2032) & (t) Table 57. Global Quetiapine Fumarate Sales Market Share in Volume by Application (2027-2032) Table 58. Global Quetiapine Fumarate Sales by Application (2027-2032) & (US$ Million) Table 59. Global Quetiapine Fumarate Sales Market Share in Value by Application (2027-2032) Table 60. Global Quetiapine Fumarate Price by Application (2027-2032) & (USD/kg) Table 61. North America Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 62. North America Quetiapine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 64. Europe Quetiapine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Quetiapine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 68. Latin America Quetiapine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Quetiapine Fumarate Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Quetiapine Fumarate Sales by Application (2021-2026) & (US$ Million) Table 71. AstraZeneca Company Information Table 72. AstraZeneca Business Overview Table 73. AstraZeneca Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. AstraZeneca Quetiapine Fumarate Product Portfolio Table 75. AstraZeneca Recent Development Table 76. Intas Company Information Table 77. Intas Business Overview Table 78. Intas Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Intas Quetiapine Fumarate Product Portfolio Table 80. Intas Recent Development Table 81. TAPI Company Information Table 82. TAPI Business Overview Table 83. TAPI Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. TAPI Quetiapine Fumarate Product Portfolio Table 85. TAPI Recent Development Table 86. Accord Company Information Table 87. Accord Business Overview Table 88. Accord Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Accord Quetiapine Fumarate Product Portfolio Table 90. Accord Recent Development Table 91. Hexal Company Information Table 92. Hexal Business Overview Table 93. Hexal Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Hexal Quetiapine Fumarate Product Portfolio Table 95. Hexal Recent Development Table 96. Dr.Reddy's Company Information Table 97. Dr.Reddy's Business Overview Table 98. Dr.Reddy's Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Dr.Reddy's Quetiapine Fumarate Product Portfolio Table 100. Dr.Reddy's Recent Development Table 101. Lupin Company Information Table 102. Lupin Business Overview Table 103. Lupin Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. Lupin Quetiapine Fumarate Product Portfolio Table 105. Lupin Recent Development Table 106. Sun Pharmaceutical Company Information Table 107. Sun Pharmaceutical Business Overview Table 108. Sun Pharmaceutical Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. Sun Pharmaceutical Quetiapine Fumarate Product Portfolio Table 110. Sun Pharmaceutical Recent Development Table 111. Hunan Dongting Pharm Company Information Table 112. Hunan Dongting Pharm Business Overview Table 113. Hunan Dongting Pharm Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio Table 115. Hunan Dongting Pharm Recent Development Table 116. SuZhou NO.4 Phamaceutical Factory Company Information Table 117. SuZhou NO.4 Phamaceutical Factory Business Overview Table 118. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 119. SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio Table 120. SuZhou NO.4 Phamaceutical Factory Recent Development Table 121. Fuan Pharmaceutical Company Information Table 122. Fuan Pharmaceutical Business Overview Table 123. Fuan Pharmaceutical Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 124. Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio Table 125. Fuan Pharmaceutical Recent Development Table 126. Zhejiang Supor Pharmaceuticals Company Information Table 127. Zhejiang Supor Pharmaceuticals Business Overview Table 128. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 129. Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio Table 130. Zhejiang Supor Pharmaceuticals Recent Development Table 131. Zhejiang Huahai Pharmaceutical Company Information Table 132. Zhejiang Huahai Pharmaceutical Business Overview Table 133. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 134. Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio Table 135. Zhejiang Huahai Pharmaceutical Recent Development Table 136. North America Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 137. North America Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 138. North America Quetiapine Fumarate Sales Market Share by Country (2021-2026) Table 139. North America Quetiapine Fumarate Sales Forecast by Country (2027-2032) & (t) Table 140. North America Quetiapine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 141. North America Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Quetiapine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Quetiapine Fumarate Market Share by Country (2021-2026) Table 144. North America Quetiapine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Quetiapine Fumarate Market Share Forecast by Country (2027-2032) Table 146. Europe Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 147. Europe Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 148. Europe Quetiapine Fumarate Sales Market Share by Country (2021-2026) Table 149. Europe Quetiapine Fumarate Sales Forecast by Country (2027-2032) & (t) Table 150. Europe Quetiapine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Quetiapine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Quetiapine Fumarate Market Share by Country (2021-2026) Table 154. Europe Quetiapine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Quetiapine Fumarate Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 158. Asia-Pacific Quetiapine Fumarate Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Quetiapine Fumarate Sales Forecast by Country (2027-2032) & (t) Table 160. Asia-Pacific Quetiapine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Quetiapine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Quetiapine Fumarate Market Share by Country (2021-2026) Table 164. Asia-Pacific Quetiapine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Quetiapine Fumarate Market Share Forecast by Country (2027-2032) Table 166. Latin America Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 167. Latin America Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 168. Latin America Quetiapine Fumarate Sales Market Share by Country (2021-2026) Table 169. Latin America Quetiapine Fumarate Sales Forecast by Country (2027-2032) & (t) Table 170. Latin America Quetiapine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Quetiapine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Quetiapine Fumarate Market Share by Country (2021-2026) Table 174. Latin America Quetiapine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Quetiapine Fumarate Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Quetiapine Fumarate Sales by Country (2021-2026) & (t) Table 178. Middle East and Africa Quetiapine Fumarate Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Quetiapine Fumarate Sales Forecast by Country (2027-2032) & (t) Table 180. Middle East and Africa Quetiapine Fumarate Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Quetiapine Fumarate Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Quetiapine Fumarate Market Share by Country (2021-2026) Table 184. Middle East and Africa Quetiapine Fumarate Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Quetiapine Fumarate Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Quetiapine Fumarate Distributors List Table 189. Quetiapine Fumarate Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Quetiapine Fumarate Image Figure 2. Global Quetiapine Fumarate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quetiapine Fumarate Market Size (2021-2032) & (US$ Million) Figure 4. Global Quetiapine Fumarate Sales (2021-2032) & (t) Figure 5. Immediate Release Tablets Image Figure 6. Global Immediate Release Tablets Sales YoY Growth (2021-2032) & (t) Figure 7. Extended Release Tablets Image Figure 8. Global Extended Release Tablets Sales YoY Growth (2021-2032) & (t) Figure 9. Global Quetiapine Fumarate Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Quetiapine Fumarate Market Share by Type 2025 VS 2032 Figure 11. North America Quetiapine Fumarate Sales Market Share in Volume by Type in 2025 Figure 12. North America Quetiapine Fumarate Sales Market Share in Value by Type in 2025 Figure 13. Europe Quetiapine Fumarate Sales Market Share in Volume by Type in 2025 Figure 14. Europe Quetiapine Fumarate Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Quetiapine Fumarate Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Quetiapine Fumarate Sales Market Share in Value by Type in 2025 Figure 17. Latin America Quetiapine Fumarate Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Quetiapine Fumarate Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Quetiapine Fumarate Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Quetiapine Fumarate Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Quetiapine Fumarate Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adult Image Figure 24. Global Adult Sales YoY Growth (2021-2032) & (t) Figure 25. Others Image Figure 26. Global Others Sales YoY Growth (2021-2032) & (t) Figure 27. Global Quetiapine Fumarate Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Quetiapine Fumarate Market Share by Application 2025 VS 2032 Figure 29. North America Quetiapine Fumarate Sales Market Share in Volume by Application in 2025 Figure 30. North America Quetiapine Fumarate Sales Market Share in Value by Application in 2025 Figure 31. Europe Quetiapine Fumarate Sales Market Share in Volume by Application in 2025 Figure 32. Europe Quetiapine Fumarate Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Quetiapine Fumarate Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Quetiapine Fumarate Sales Market Share in Value by Application in 2025 Figure 35. Latin America Quetiapine Fumarate Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Quetiapine Fumarate Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Quetiapine Fumarate Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Quetiapine Fumarate Sales Market Share in Value by Application in 2025 Figure 39. North America Quetiapine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 40. North America Quetiapine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Quetiapine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Quetiapine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Quetiapine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 44. Europe Quetiapine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Quetiapine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Quetiapine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Quetiapine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 48. Asia-Pacific Quetiapine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Quetiapine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Quetiapine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Quetiapine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 52. Latin America Quetiapine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Quetiapine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Quetiapine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Quetiapine Fumarate Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 56. Middle East and Africa Quetiapine Fumarate Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Quetiapine Fumarate Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Quetiapine Fumarate Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Quetiapine Fumarate Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Quetiapine Fumarate Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Immediate Release Tablets
  • Extended Release Tablets
Applications
  • Adult
  • Others
Companies covered
  • AstraZeneca
  • Intas
  • TAPI
  • Accord
  • Hexal
  • Dr.Reddy's
  • Lupin
  • Sun Pharmaceutical
  • Hunan Dongting Pharm
  • SuZhou NO.4 Phamaceutical Factory
  • Fuan Pharmaceutical
  • Zhejiang Supor Pharmaceuticals
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Quetiapine Fumarate Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Quetiapine Fumarate Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Quetiapine Fumarate Market by Type
  6. 1.3.1 Immediate Release Tablets
  7. 1.3.2 Extended Release Tablets
  8. 1.4 Global Quetiapine Fumarate Market Size by Type
  9. 1.4.1 Global Quetiapine Fumarate Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Quetiapine Fumarate Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Quetiapine Fumarate Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Quetiapine Fumarate Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Quetiapine Fumarate Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Quetiapine Fumarate Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Quetiapine Fumarate Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Quetiapine Fumarate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Quetiapine Fumarate Industry Trends
  2. 2.2 Quetiapine Fumarate Industry Drivers
  3. 2.3 Quetiapine Fumarate Industry Opportunities and Challenges
  4. 2.4 Quetiapine Fumarate Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Quetiapine Fumarate Revenue (2021-2026)
  2. 3.2 Global Top Players by Quetiapine Fumarate Sales (2021-2026)
  3. 3.3 Global Top Players by Quetiapine Fumarate Price (2021-2026)
  4. 3.4 Global Quetiapine Fumarate Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Quetiapine Fumarate Major Company Production Sites & Headquarters
  6. 3.6 Global Quetiapine Fumarate Company, Product Type & Application
  7. 3.7 Global Quetiapine Fumarate Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Quetiapine Fumarate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Quetiapine Fumarate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Quetiapine Fumarate Tier 1, Tier 2, and Tier 3
4 Quetiapine Fumarate Regional Status and Outlook
  1. 4.1 Global Quetiapine Fumarate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Quetiapine Fumarate Historic Market Size by Region
  3. 4.2.1 Global Quetiapine Fumarate Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Quetiapine Fumarate Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Quetiapine Fumarate Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Quetiapine Fumarate Forecasted Market Size by Region
  7. 4.3.1 Global Quetiapine Fumarate Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Quetiapine Fumarate Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Quetiapine Fumarate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Quetiapine Fumarate by Application
  1. 5.1 Quetiapine Fumarate Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Others
  4. 5.2 Global Quetiapine Fumarate Market Size by Application
  5. 5.2.1 Global Quetiapine Fumarate Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Quetiapine Fumarate Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Quetiapine Fumarate Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Quetiapine Fumarate Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Quetiapine Fumarate Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Quetiapine Fumarate Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Quetiapine Fumarate Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Quetiapine Fumarate Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AstraZeneca
  2. 6.1.1 AstraZeneca Company Information
  3. 6.1.2 AstraZeneca Business Overview
  4. 6.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AstraZeneca Quetiapine Fumarate Product Portfolio
  6. 6.1.5 AstraZeneca Recent Developments
  7. 6.2 Intas
  8. 6.2.1 Intas Company Information
  9. 6.2.2 Intas Business Overview
  10. 6.2.3 Intas Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Intas Quetiapine Fumarate Product Portfolio
  12. 6.2.5 Intas Recent Developments
  13. 6.3 TAPI
  14. 6.3.1 TAPI Company Information
  15. 6.3.2 TAPI Business Overview
  16. 6.3.3 TAPI Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 TAPI Quetiapine Fumarate Product Portfolio
  18. 6.3.5 TAPI Recent Developments
  19. 6.4 Accord
  20. 6.4.1 Accord Company Information
  21. 6.4.2 Accord Business Overview
  22. 6.4.3 Accord Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Accord Quetiapine Fumarate Product Portfolio
  24. 6.4.5 Accord Recent Developments
  25. 6.5 Hexal
  26. 6.5.1 Hexal Company Information
  27. 6.5.2 Hexal Business Overview
  28. 6.5.3 Hexal Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hexal Quetiapine Fumarate Product Portfolio
  30. 6.5.5 Hexal Recent Developments
  31. 6.6 Dr.Reddy's
  32. 6.6.1 Dr.Reddy's Company Information
  33. 6.6.2 Dr.Reddy's Business Overview
  34. 6.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Dr.Reddy's Quetiapine Fumarate Product Portfolio
  36. 6.6.5 Dr.Reddy's Recent Developments
  37. 6.7 Lupin
  38. 6.7.1 Lupin Company Information
  39. 6.7.2 Lupin Business Overview
  40. 6.7.3 Lupin Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lupin Quetiapine Fumarate Product Portfolio
  42. 6.7.5 Lupin Recent Developments
  43. 6.8 Sun Pharmaceutical
  44. 6.8.1 Sun Pharmaceutical Company Information
  45. 6.8.2 Sun Pharmaceutical Business Overview
  46. 6.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sun Pharmaceutical Quetiapine Fumarate Product Portfolio
  48. 6.8.5 Sun Pharmaceutical Recent Developments
  49. 6.9 Hunan Dongting Pharm
  50. 6.9.1 Hunan Dongting Pharm Company Information
  51. 6.9.2 Hunan Dongting Pharm Business Overview
  52. 6.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Hunan Dongting Pharm Quetiapine Fumarate Product Portfolio
  54. 6.9.5 Hunan Dongting Pharm Recent Developments
  55. 6.10 SuZhou NO.4 Phamaceutical Factory
  56. 6.10.1 SuZhou NO.4 Phamaceutical Factory Company Information
  57. 6.10.2 SuZhou NO.4 Phamaceutical Factory Business Overview
  58. 6.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Product Portfolio
  60. 6.10.5 SuZhou NO.4 Phamaceutical Factory Recent Developments
  61. 6.11 Fuan Pharmaceutical
  62. 6.11.1 Fuan Pharmaceutical Company Information
  63. 6.11.2 Fuan Pharmaceutical Business Overview
  64. 6.11.3 Fuan Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Fuan Pharmaceutical Quetiapine Fumarate Product Portfolio
  66. 6.11.5 Fuan Pharmaceutical Recent Developments
  67. 6.12 Zhejiang Supor Pharmaceuticals
  68. 6.12.1 Zhejiang Supor Pharmaceuticals Company Information
  69. 6.12.2 Zhejiang Supor Pharmaceuticals Business Overview
  70. 6.12.3 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Zhejiang Supor Pharmaceuticals Quetiapine Fumarate Product Portfolio
  72. 6.12.5 Zhejiang Supor Pharmaceuticals Recent Developments
  73. 6.13 Zhejiang Huahai Pharmaceutical
  74. 6.13.1 Zhejiang Huahai Pharmaceutical Company Information
  75. 6.13.2 Zhejiang Huahai Pharmaceutical Business Overview
  76. 6.13.3 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Zhejiang Huahai Pharmaceutical Quetiapine Fumarate Product Portfolio
  78. 6.13.5 Zhejiang Huahai Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Quetiapine Fumarate Sales by Country
  2. 7.1.1 North America Quetiapine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Quetiapine Fumarate Sales by Country (2021-2026)
  4. 7.1.3 North America Quetiapine Fumarate Sales Forecast by Country (2027-2032)
  5. 7.2 North America Quetiapine Fumarate Market Size by Country
  6. 7.2.1 North America Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Quetiapine Fumarate Market Size by Country (2021-2026)
  8. 7.2.3 North America Quetiapine Fumarate Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Quetiapine Fumarate Sales by Country
  2. 8.1.1 Europe Quetiapine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Quetiapine Fumarate Sales by Country (2021-2026)
  4. 8.1.3 Europe Quetiapine Fumarate Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Quetiapine Fumarate Market Size by Country
  6. 8.2.1 Europe Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Quetiapine Fumarate Market Size by Country (2021-2026)
  8. 8.2.3 Europe Quetiapine Fumarate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Quetiapine Fumarate Sales by Country
  2. 9.1.1 Asia-Pacific Quetiapine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Quetiapine Fumarate Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Quetiapine Fumarate Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Quetiapine Fumarate Market Size by Country
  6. 9.2.1 Asia-Pacific Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Quetiapine Fumarate Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Quetiapine Fumarate Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Quetiapine Fumarate Sales by Country
  2. 10.1.1 South America Quetiapine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Quetiapine Fumarate Sales by Country (2021-2026)
  4. 10.1.3 South America Quetiapine Fumarate Sales Forecast by Country (2027-2032)
  5. 10.2 South America Quetiapine Fumarate Market Size by Country
  6. 10.2.1 South America Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Quetiapine Fumarate Market Size by Country (2021-2026)
  8. 10.2.3 South America Quetiapine Fumarate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Quetiapine Fumarate Sales by Country
  2. 11.1.1 Middle East and Africa Quetiapine Fumarate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Quetiapine Fumarate Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Quetiapine Fumarate Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Quetiapine Fumarate Market Size by Country
  6. 11.2.1 Middle East and Africa Quetiapine Fumarate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Quetiapine Fumarate Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Quetiapine Fumarate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Quetiapine Fumarate Value Chain Analysis
  2. 12.1.1 Quetiapine Fumarate Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Quetiapine Fumarate Production Mode & Process
  7. 12.2 Quetiapine Fumarate Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Quetiapine Fumarate Distributors
  10. 12.2.3 Quetiapine Fumarate Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst